EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetics of doxycycline hyclate in pigs with a new feed premix formulation

Mónica Zermeño-Acosta iD, Héctor Sumano iD, Jorge Luna-Del Villar iD, Maria Josefa Bernad iD, Lilia Gutiérrez iD

Journal of Veterinary Pharmacology and Therapeutics · 2024

DOI: 10.1111/jvp.13419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2024. Verfasst von Mónica Zermeño-Acosta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Fisiología y Farmacología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, México City, Mexico. Hauptthemen laut MEDLINE: Doxycycline, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the administration of doxycycline hyclate in a long‐acting pharmaceutical preparation in pigs when administered either ad libitum as a feed medication or an oral bolus dose. In all instances, the studied dose was 20 mg/kg b.w. A total of 48 healthy crossbred, castrated male pigs (Landrace‐Yorkshire) weighing 23 ± 4.3 kg were included in this trial. They were randomly assigned to six groups as follows: two groups for the experimental prototype 1 of doxycycline hyclate administering it ad libitum (Fad‐lib) or as forced bolus (Fbolus); two groups for the experimental prototype 2 of doxycycline hyclate as for the former groups (FCad‐lib and FCbolus), and two control groups receiving the same dose of doxycycline hyclate, but of a commercial premix, also as previously explained (Cbolus and Cad‐lib). Statistical analysis of the mean pharmacokinetic values was carried out with Kruskal–Wallis and Dunn's tests. The relative bioavailability (Fr) of the best prototype, when administered ad libitum (FCad‐lib), was five times larger than the reference group (Cadlib). These results allow the proposal that the referred differences achieved in the presented prototypes can mark a notable clinical difference, particularly in pathogens with some resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxycyclineAnti-Bacterial AgentsMaleAnimalsSwineBiological AvailabilityArea Under CurveHalf-Life

Stichwörter der Autor:innen

bioavailabilitydosage formdoxycycline hyclatepigs

Substanzen

DoxycyclineAnti-Bacterial Agents

Autor:innen und Institutionen

  • Departamento de Fisiología y Farmacología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, México City, Mexico.
  • Departamento de Cirugía, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, México City, Mexico.
  • Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, México City, Mexico.

ORCID-Profile: Mónica Zermeño-Acosta, Héctor Sumano, Jorge Luna-Del Villar, Maria Josefa Bernad, Lilia Gutiérrez

Zitieren

APA

Zermeño-Acosta, M., Sumano, H., Villar, J. L., Bernad, M. J., & Gutiérrez, L. (2024). Pharmacokinetics of doxycycline hyclate in pigs with a new feed premix formulation. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.13419

Vancouver

Zermeño-Acosta M, Sumano H, Villar JL, Bernad MJ, Gutiérrez L. Pharmacokinetics of doxycycline hyclate in pigs with a new feed premix formulation. Journal of Veterinary Pharmacology and Therapeutics. 2024. doi:10.1111/jvp.13419

BibTeX
@article{ZermeoAcosta2024,
  author = {Zermeño-Acosta, Mónica and Sumano, Héctor and Villar, Jorge Luna-Del and Bernad, Maria Josefa and Gutiérrez, Lilia},
  title = {Pharmacokinetics of doxycycline hyclate in pigs with a new feed premix formulation},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.1111/jvp.13419}
}
Kostenlos starten →